what is glp -1 GLP-1 & Does it Affect Weight & Cognition? GLP-1 Drugs from the Gray

Frequently Asked Questions Orforglipron (LY3502970) is an investigational oral, non-peptide, small-molecule GLP-1 receptor agonist developed by Eli Lilly

rxlist.com (Byetta ) rxlist.com (Byduron ) extended release formulation Keywords Liraglutide Trade Names: Victoza & generic Pharmacology: GLP-1 analog mechanism of action is the same as exenatide Indications: an adjunct to diet and exercise to improve glycemic control in type 2 diabetes mellitus to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease Pharmacokinetics: once-daily injection Side Effects: Most common : nausea, diarrhea, vomiting (similar to exenatide) Black Box Warning: RISK OF THYROID C-CELL TUMORS References: Masharani U, Kroon L (2024): Pancreatic Hormones & Antidiabetic Drugs (Chapter 41)

Start Your Weight Loss Journey Today We all have to start somewhere

The new HHS proposal, they said, would require both Medicare and Medicaid to cover the drugs for people with obesity as a treatment for the condition

Just because you want to lose weight does not mean GLP-1 medications are appropriate for you